That’s why we’re excited to announce that Wegovy® – a groundbreaking once-weekly weight management injection – will be available from July.
Wegovy is a prescription-only weekly injection used to support long-term weight management in adults and adolescents. It contains semaglutide, a medicine that mimics a natural hormone (GLP-1) that helps regulate appetite, food intake, and body weight.
Wegovy is used alongside a reduced-calorie diet and increased physical activity for:
Adults:
Adolescents (12 years and over):
Wegovy helps you feel full earlier and stay full longer, reducing your hunger and food cravings. This makes it easier to eat less and lose weight.
It also helps improve health markers such as:
In people with cardiovascular disease and a BMI ≥ 27, Wegovy also reduces the risk of heart attack, stroke, or death from cardiovascular causes.
If side effects occur, your doctor may slow or pause the dose increases.
Most side effects are mild and reduce over time. Common ones include:
Less common but serious risks:
Tell your doctor immediately if you experience:
Wegovy is not suitable if you:
Clinical trials showed an average weight loss of 15% over 68 weeks in adults — results may vary.
No. It is not insulin. It is a GLP-1 receptor agonist, which helps regulate appetite and blood sugar.
Yes, as long as it’s effective and well tolerated. It should be part of a long-term weight management plan.
Take the missed dose within 5 days. If more than 5 days pass, skip that dose and take the next one as scheduled.
Our pharmacists at PillDrop are here to support you with:
Contact us today to learn more or talk to your doctor to see if Wegovy is right for you.